Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients

ConclusionsOur study revealed the clinical characteristics and prognoses of patients who became ineligible for the PACIFIC trial after CRT. Physicians should be careful while prescribing CRT for patients with characteristics such as old age, male gender, and radiation therapy with V20 ≥ 35%.

http://link.springer.com/10.1007/s00280-019-03885-4

Source: Cancer Chemotherapy and Pharmacology - July 15, 2019 Category: Cancer & Oncology Source Type: research